Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
about
Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).Clonality and molecular pathogenesis of mastocytosis.Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies.Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.KIT and mastocytosis.Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.Current state of biology and diagnosis of clonal mast cell diseases in adults.Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.
P2860
Q33658543-9071D31B-4083-4F80-A70A-BBBFCF08F677Q35757696-9A21CAAF-4960-4257-A602-01ADCA122DB9Q35769811-7EBDB098-69CD-4634-A6E2-7CA7C7C4D822Q36182758-7E48EED9-C152-419A-A2C5-5642CECE6410Q36289034-799ABD6D-2F03-403A-884B-BB0326495D84Q36842503-AF5D1625-8000-40B3-A5E8-A49DAE90456CQ37195681-7863FA4E-5C03-4A7C-A488-6EF9B7EACCD4Q37379320-58C64E91-B7F2-4FF7-9C24-E102514C351EQ37992835-50E2C763-08ED-487B-A465-E92C3BE39ABDQ38007005-0AD81863-02F9-45DB-A68A-1CDCBC61E72CQ38110527-BC5CDE40-CAD0-4346-ACB8-BCCB94D43033Q38358282-F2E42775-9866-4DBA-AC60-CD927B119D37Q39267824-12B18DF0-5E8C-44C9-BAEF-C30A25A7CBF5Q45058347-94446364-DA15-443C-94E4-1FB25DF40C78Q50900052-F1417F5F-36AF-4A07-A609-77A30B5CB58BQ54234141-53C1F6F6-3943-4F4C-8FC2-0200E162B6DFQ54721275-BC35D77D-F378-4CBA-905D-35867AD28EA2
P2860
Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Demonstration that mast cells, ...... of patients with mastocytosis.
@ast
Demonstration that mast cells, ...... of patients with mastocytosis.
@en
type
label
Demonstration that mast cells, ...... of patients with mastocytosis.
@ast
Demonstration that mast cells, ...... of patients with mastocytosis.
@en
prefLabel
Demonstration that mast cells, ...... of patients with mastocytosis.
@ast
Demonstration that mast cells, ...... of patients with mastocytosis.
@en
P2093
P2860
P1476
Demonstration that mast cells, ...... of patients with mastocytosis.
@en
P2093
Dean D Metcalfe
Devinder Sehgal
Harold Obiakor
Marcia L Taylor
Mark Raffeld
Rose G Mage
P2860
P304
P356
10.1016/S1525-1578(10)60529-6
P50
P577
2004-11-01T00:00:00Z